| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $119.5M | +5.1% |
| Cost of Revenue | $72.7M | -3.2% |
| Gross Profit | $46.8M | +21.2% |
| R&D Expense | $21.2M | -44.7% |
| SG&A Expense | $37.9M | -13.0% |
| Operating Income | -$66.7M | +41.2% |
| Interest Expense | $14.0M | -41.6% |
| Pre-tax Income | -$80.9M | +36.5% |
| Income Tax | $718K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.0M | -71.8% |
| Short-term Investments | $133.9M | +286.3% |
| Accounts Receivable | $28.3M | -20.5% |
| Inventory | $47.6M | -19.8% |
| Current Assets | $250.9M | -2.8% |
| Total Assets | $264.5M | -4.1% |
| Current Liabilities | $37.6M | -17.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.3M | +60.2% |
| Capital Expenditures | $798K | -12.5% |
| Investing Cash Flow | -$97.7M | -194.0% |
| Financing Cash Flow | $55.5M | -18.2% |
| Free Cash Flow | -$47.1M | +59.8% |
| +46.2% |
| Net Income | -$81.7M | +36.2% |
| EPS (Basic) | -$5.37 | -118.3% |
| EPS (Diluted) | -$5.37 | -118.3% |
| Long-term Debt |
| $96.2M |
| -51.2% |
| Total Liabilities | $137.5M | -44.8% |
| Stockholders' Equity | $127.0M | +373.4% |